VOGLISTAR MD 0.2 10'S

About

Voglistar MD 0.2 is an orally disintegrating tablet containing Voglibose 0.2mg, an alpha-glucosidase inhibitor, specifically formulated for the management of type 2 diabetes mellitus. Voglibose acts by inhibiting the activity of alpha-glucosidase enzymes in the small intestine, which are crucial for the breakdown of complex carbohydrates into simpler sugars. By slowing down this enzymatic process, Voglibose effectively delays the absorption of glucose into the bloodstream after meals, thereby significantly reducing postprandial hyperglycemia. This mechanism is particularly beneficial for individuals who experience pronounced blood sugar spikes following food intake. The orally disintegrating tablet (MD) offers enhanced patient convenience, making it easier to administer, especially for those with swallowing difficulties. Voglistar MD 0.2 is typically prescribed as an adjunct to dietary modifications and regular exercise, either as a standalone therapy or in combination with other oral antidiabetic agents, to achieve optimal glycemic control.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of postprandial blood glucose levels.
• Used as an adjunct to diet and exercise.
• As monotherapy or in combination therapy.

Directions For Use

Place the orally disintegrating tablet on the tongue, allow it to dissolve, and then swallow with saliva, usually immediately before meals.

Benefits

• Effectively reduces post-meal blood sugar spikes.
• Delays carbohydrate absorption.
• Low risk of hypoglycemia when used alone.
• Convenient orally disintegrating formulation.
• Can be used in combination with other antidiabetics.
• Helps improve overall glycemic control.

Side Effects

• Flatulence
• Abdominal distension
• Diarrhea
• Abdominal pain
• Nausea
• Vomiting
• Heartburn
• Constipation
• Skin rash (rare)
• Hepatitis (rare)
• Increased liver enzymes (rare)
• Hypoglycemia (when combined with sulfonylureas/insulin)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided as it may affect blood sugar levels.
• Pregnancy - Consult your doctor. This medication is generally not recommended during pregnancy unless clearly necessary, as its safety has not been fully established.
• Breastfeeding - Consult your doctor. It is unknown if Voglibose passes into breast milk, and its use during breastfeeding should be carefully considered.
• Liver - Use with caution in patients with liver impairment. Regular monitoring of liver function tests is recommended during treatment.
• Kidney - Use with caution in patients with severe kidney impairment. Your doctor will assess suitability and dosage.
• Lung - No specific contraindications, but general health should be considered.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.